Positron Revenue 2010-2024 | POSC

Positron revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

Positron Revenue 2010-2024 | POSC

Positron revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$217.3B
Intuitive Surgical (ISRG)$204B
Alcon (ALC)$45.1B
Edwards Lifesciences (EW)$42B
IQVIA Holdings (IQV)$35.9B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$33.8B
Waters (WAT)$24B
STERIS (STE)$21.7B
SONOVA HOLDING (SONVY)$20.8B
Hologic (HOLX)$16.1B
Fresenius Medical Care AG KGaA (FMS)$14.6B
Globus Medical (GMED)$12.6B
Sysmex ADR (SSMXY)$12.2B
Penumbra (PEN)$10.4B
Masimo (MASI)$9.5B
Glaukos (GKOS)$8.8B
Teleflex (TFX)$8.4B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.8B
Veracyte (VCYT)$3.4B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Tandem Diabetes Care (TNDM)$2.4B
Elekta AB (EKTAY)$2.3B
TransMedics (TMDX)$2.2B
Integra LifeSciences Holdings (IART)$2B
Alphatec Holdings (ATEC)$1.7B
Artivion (AORT)$1.3B